ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,689, issued on Nov. 25, was assigned to AbbVie Biotherapeutics Inc. (North Chicago, Ill.).
"Anti-CD19 antibody drug conjugates" was invented by James W. Purcell (San Francisco).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides anti-CD19 antibody drug conjugates (ADCs), including compositions and methods of using such ADCs."
The patent was filed on Oct. 18, 2024, under Application No. 18/920,375.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12478689&OS...